ENDPOINTS

Zealand partners with Roche on petrelintide in a deal worth up to $5.3B

Zealand Pharma has finally found a partner. Zealand said Wednesday it will be working with Roche on its lead obesity candidate petrelintide, with the Swiss pharma paying $1.65 billion upfront in ...

Mar 12, 2025 - 09:33
 0
Zealand partners with Roche on petrelintide in a deal worth up to $5.3B
Zealand Pharma has finally found a partner. Zealand said Wednesday it will be working with Roche on its lead obesity candidate petrelintide, with the Swiss pharma paying $1.65 billion upfront in ...
Read More

Tags:

Previous Article

SpaceX craft to launch to retrieve 2 astronauts who have been swept up in politics

Next Article

‘Global weirding’: climate whiplash hitting world’s biggest cities, study reveals

Related Posts

Bayer eyes capital raise as it grapples with Monsanto cases

Bayer eyes capital raise as it grapples with Monsanto c...

Mar 7, 2025  0

Pacira absorbs GQ Bio for $32M; Layoffs at BMS, Eisai and CRISPR Therapeutics

Pacira absorbs GQ Bio for $32M; Layoffs at BMS, Eisai a...

Feb 28, 2025  0

Some FDA medical device staff reinstated just days after firings

Some FDA medical device staff reinstated just days afte...

Feb 24, 2025  0